Understand the source comparison
Best Research Peptides for GERD: Mechanism Comparison
BPC-157 Angiogenesis, mucosal protection VEGFR2, FAK-paxillin signaling 14–21 days for 60–70% lesion reduction 40+ preclinical studies in gastric injury models Strongest evidence for direct tissue repair; gold standard for gastric cytoprotection research Thymo
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- BPC-157
- Angiogenesis, mucosal protection
- VEGFR2, FAK-paxillin signaling
- 14–21 days for 60–70% lesion reduction
- 40+ preclinical studies in gastric injury models
- Strongest evidence for direct tissue repair; gold standard for gastric cytoprotection research
- Thymosin Beta-4
- Actin polymerization, cell migration
- G-actin sequestration, integrin activation
- 21–28 days for epithelial barrier restoration
- 20+ studies in wound healing and inflammation
- Complementary to BPC-157; addresses inflammation and barrier function
- KP-102 (Ghrelin Agonist)
- Gastric motility, LES tone enhancement
- Ghrelin receptor activation
- Not applicable. Functional improvement, not lesion healing
- 12+ studies in motility disorders
- Targets reflux prevention rather than tissue repair; different application
- Pentadecapeptide BPC
- Microcirculation stabilization, anti-inflammatory
- Leukocyte adhesion inhibition
- 14–21 days for microvascular protection
- 30+ studies overlapping with BPC-157 research
- Nearly identical to BPC-157 in structure and function; used interchangeably in literature